DR HORTON ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at USD 41.94 USD in weekly data.
● The close medium term support offers good timing for purchasing the stock.
● The company returns high margins, thereby supporting business profitability.
● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
● The company's attractive earnings multiples are brought to light by a P/E ratio at 11.85 for the current year.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● The stock is in a well-established, long-term rising trend above the technical support level at 41.94 USD
